References
- Beasley GM, Ross MI, Tyler DS. Future directions in regional treatment strategies for melanoma and sarcoma. Int J Hyperthermia 2008; 24: 301–309
- Noorda EM, Vrouenraets BC, Nieweg OE, Klaase JM, Van der Zee J, Kroon BBR. Long-term results of a double perfusion schedule using high dose hyperthermia and melphalan sequentially in extensive melanoma of the lower limb. Melanoma research 2003; 13: 395–399
- Van der Zee J, Kroon BBR, Nieweg OE, Van de Merwe SA, Kampinga HH. Rationale for different approaches to combined melphalan and hyperthermia in regional isolated perfusion. Eur J Cancer 1997; 33: 1546–1550
- Lindner P, Doubrovsky A, Kam PCA, Thompson JF. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol 2002; 9: 127–136
- Kroon BBR, Geel van AN, Benckhuijsen C, Wieberdink J. Normothermic isolated perfusion with Melphalan for advanced melanoma of the limbs. Anticancer Res 1987; 7: 441–442